
Benjamin A. Ailes
Examiner (ID: 2836)
| Most Active Art Unit | 2442 |
| Art Unit(s) | 2442, 2142 |
| Total Applications | 236 |
| Issued Applications | 110 |
| Pending Applications | 6 |
| Abandoned Applications | 120 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20517582
[patent_doc_number] => 20260041685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => METHODS OF TREATING INDOLENT SYSTEMIC MASTOCYTOSIS
[patent_app_type] => utility
[patent_app_number] => 19/305502
[patent_app_country] => US
[patent_app_date] => 2025-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19305502
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/305502 | Methods of treating indolent systemic mastocytosis | Aug 19, 2025 | Issued |
| 18/716513 | SILVER ION COMPLEX GEMINI QUATERNARY AMMONIUM SALT: PREPARATION METHOD AND APPLICATIONS | Jun 4, 2024 | Pending |
Array
(
[id] => 19658432
[patent_doc_number] => 20240425497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => Cbl-b Inhibitors and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/654773
[patent_app_country] => US
[patent_app_date] => 2024-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/654773 | Cbl-b Inhibitors and Methods of Use Thereof | May 2, 2024 | Pending |
Array
(
[id] => 19125654
[patent_doc_number] => 20240131007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/480268
[patent_app_country] => US
[patent_app_date] => 2023-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480268
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480268 | METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS | Oct 2, 2023 | Pending |
Array
(
[id] => 19081829
[patent_doc_number] => 20240108630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => METHODS FOR INHIBITING RAS
[patent_app_type] => utility
[patent_app_number] => 18/479500
[patent_app_country] => US
[patent_app_date] => 2023-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18479500
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/479500 | METHODS FOR INHIBITING RAS | Oct 1, 2023 | Pending |
Array
(
[id] => 20171712
[patent_doc_number] => 12390432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Methods for treating allan-herndon-dudley syndrome
[patent_app_type] => utility
[patent_app_number] => 18/350116
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350116
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350116 | Methods for treating allan-herndon-dudley syndrome | Jul 10, 2023 | Issued |
Array
(
[id] => 18451367
[patent_doc_number] => 20230192645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => INDOLE CARBOXAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/173170
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173170
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173170 | INDOLE CARBOXAMIDE COMPOUNDS | Feb 22, 2023 | Pending |
Array
(
[id] => 19996680
[patent_doc_number] => 20250134902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-01
[patent_title] => DRUG REPURPOSING FOR DELAYED TREATMENT OF ISCHEMIC STROKE
[patent_app_type] => utility
[patent_app_number] => 18/726054
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726054
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/726054 | DRUG REPURPOSING FOR DELAYED TREATMENT OF ISCHEMIC STROKE | Feb 8, 2023 | Pending |
Array
(
[id] => 20254804
[patent_doc_number] => 12427137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-30
[patent_title] => Method for reducing methane production in animal stomach
[patent_app_type] => utility
[patent_app_number] => 18/104459
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18104459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/104459 | Method for reducing methane production in animal stomach | Jan 31, 2023 | Issued |
Array
(
[id] => 18739438
[patent_doc_number] => 20230348360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Amino Lipid and Preparation Method and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 18/100596
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100596 | Amino Lipid and Preparation Method and Application Thereof | Jan 23, 2023 | Pending |
Array
(
[id] => 19875796
[patent_doc_number] => 20250108053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => RIBOCICLIB PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/730975
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18730975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/730975 | RIBOCICLIB PHARMACEUTICAL COMPOSITIONS | Jan 22, 2023 | Pending |
Array
(
[id] => 20226311
[patent_doc_number] => 12414951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Use of compound in preparation of medicament for prophylaxis and treatment of inflammatory tissue damage
[patent_app_type] => utility
[patent_app_number] => 18/156095
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 0
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156095 | Use of compound in preparation of medicament for prophylaxis and treatment of inflammatory tissue damage | Jan 17, 2023 | Issued |
Array
(
[id] => 19983952
[patent_doc_number] => 20250122174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same
[patent_app_type] => utility
[patent_app_number] => 18/728660
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18728660
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/728660 | Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same | Jan 11, 2023 | Pending |
Array
(
[id] => 18483564
[patent_doc_number] => 20230210862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => FORMULATION AND METHOD FOR TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/147030
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147030 | FORMULATION AND METHOD FOR TREATING PROSTATE CANCER | Dec 27, 2022 | Abandoned |
Array
(
[id] => 19613152
[patent_doc_number] => 20240398832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => CDK4 AND 6 INHIBITOR IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS PREVIOUSLY TREATED WITH A CDK4 AND 6 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/717475
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18717475
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/717475 | CDK4 AND 6 INHIBITOR IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS PREVIOUSLY TREATED WITH A CDK4 AND 6 INHIBITOR | Dec 6, 2022 | Pending |
Array
(
[id] => 18690924
[patent_doc_number] => 20230321091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/053350
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/053350 | SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES | Nov 6, 2022 | Pending |
Array
(
[id] => 20693968
[patent_doc_number] => 20260125374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-05-07
[patent_title] => PI3K-ALPHA INHIBITORS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/706511
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18706511
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/706511 | PI3K-ALPHA INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Nov 2, 2022 | Pending |
Array
(
[id] => 19658479
[patent_doc_number] => 20240425544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => STEREOSELECTIVE STEROIDAL REDUCTIONS
[patent_app_type] => utility
[patent_app_number] => 18/704844
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18704844
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/704844 | STEREOSELECTIVE STEROIDAL REDUCTIONS | Oct 31, 2022 | Pending |
Array
(
[id] => 20706577
[patent_doc_number] => 20260130905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-05-14
[patent_title] => TOPICAL FORMULATIONS OF DEUCRAVACITINIB
[patent_app_type] => utility
[patent_app_number] => 18/705178
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18705178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/705178 | TOPICAL FORMULATIONS OF DEUCRAVACITINIB | Oct 26, 2022 | Pending |
Array
(
[id] => 19065646
[patent_doc_number] => 20240100072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/975267
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975267 | SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE | Oct 26, 2022 | Abandoned |